Loading, please wait...
There is no cost to attend, but you must register before the activity begins to reserve your space.
There is no charge for CME credit.
Following the activity, pharmacists will be provided with instructions to claim ACPE credit if desired ($15).
If you have any questions, please contact cpdsa@uscmed.sc.edu .
There is no charge for CME credit.
Following the activity, pharmacists will be provided with instructions to claim ACPE credit if desired ($15).
If you have any questions, please contact cpdsa@uscmed.sc.edu .
This activity is approved for the state of South Carolina Board of Medical Examiner’s continuing education (CE) requirement for 2 hours related to prescribing and monitoring controlled substances for physicians and will satisfy the South Carolina Board of Pharmacy’s requirement for 1.0 hour of CE related to controlled substances for pharmacists.
Target Audience: Primary Care Clinicians within Prisma Health including: Physicians, Pharmacists, Physician Assistants, and Nurse Practitioners
Learning Objectives:
At the conclusion of this activity, the participant will be able to:
- Discuss bias and stigma in the context of pain and addiction
- Apply safe and evidence-based prescribing of non-opioids and opioids
- Treat pain and OUD (Opioid Use Disorder) safely through pharmacologic and non-pharmacologic methods
Date: May 17, 2022 12:00 PM - 01:00 PM
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
University of South Carolina School of Medicine; Prisma Health Medical Group;
Requirements for CE Credit
Participants must login to the teleconference to view presentation, participate in interactivity and note session code provided at the end of the presentation.
To claim credit for this activity, participants must complete an online program evaluation and must update their accounts to properly reflect their month and day of birth and their correct NABP E-Id. Registration with a proper disclosure of your NABP E-Id is a requirement for receiving Continuing Pharmacy Education. To register with or look up your NABP E-Id, please click on the CPE Monitor logo below to be directed to their site. Evaluations should be completed within 30 days of the live event to ensure transmission to the NABP CPE Monitor. Any credit submitted more than 60 days from the date of the event will not be accepted by the CPE Monitor. If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-profile.
At the completion of this activity, the participant will be able to:
- Discuss bias and stigma in the context of pain and addiction
- Apply safe and evidence-based prescribing of non-opioids and opioids
- Treat pain and OUD (Opioid Use Disorder) safely through pharmacologic and non-pharmacologic methods
Speaker(s)/Author(s)
|
Kevin Walker, MD, FASA
|
|
|
Paul Bornemann, MD, RMSK, RPVI
|
Activity Number
0062-9999-21-120-L08-P
Date:
05/17/22
Time:
12:00 PM - 01:00 PM
CE Hours
1.00